The Search for Solutions to the Delivery Challenges of Nucleic Acid-Based Therapies
In this webinar, our panel of scientific experts and entrepreneurs highlight some of the key delivery challenges facing the field of gene and nucleic acid therapeutics and discuss select scientific innovations that are being undertaken with the aim to address these challenges. Discussion topics include both viral and non-viral systems for delivery of DNA, mRNA, siRNA/ASO payloads in addition to cell/tissue specific targeting approaches.
Please note: This is the recording of a webinar which took place on April 06, 2022.
You are watching a rebroadcast of the webinar. There will not be a live Q&A session following the presentation. If you have any questions for the speakers, please email [email protected]
DISCLAIMER: The information on this webpage, including in the videos, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is for informational purposes only. This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates. The information presented in the videos is specific and applicable to region in which the original presentation took place. Many videos contain information from, or sessions given by, third parties. Please note that only those third parties that provide this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in these videos, and JJI makes no representations, warranties, or assurances, express or implied, as to the content or the information presented and is not responsible for any use of this information by you.